Carbamic Acid

Carbamic Acid

SCHEMBL28520575

Cc1cc(C)c(CNC(=O)O)c(C)c1.NC(=O)O

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCL2 P10415 1/20 0.44
BCL2L1 Q07817 1/20 0.44
MCL1 Q07820 1/20 0.44
P2RX7 Q99572 1/20 0.43
LIPG Q9Y5X9 1/20 0.42
LMNA P02545 1/20 0.41
KDM4E B2RXH2 3/20 0.40
TPMT P51580 1/20 0.39
CYP1A2 P05177 2/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
TSHR P16473 1/20 0.38
CYP2C19 P33261 1/20 0.38
KLKB1 P03952 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
ATM Q13315 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
NPC1 O15118 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1694515 0.94 BCL2 (0.48) BCL2BCL2L1MCL1P2RX7LIPG
SCHEMBL9210068 0.86 BCL2 (0.46) BCL2BCL2L1MCL1P2RX7LIPG
SCHEMBL30035793 0.85 BCL2 (0.39) BCL2BCL2L1MCL1P2RX7LIPG
SCHEMBL6017718 0.80 BCL2 (0.47) BCL2BCL2L1MCL1P2RX7LIPG
SCHEMBL28520572 0.79 BCL2 (0.41) BCL2BCL2L1MCL1P2RX7LIPG
SCHEMBL13537421 0.78 BCL2 (0.46) BCL2BCL2L1MCL1P2RX7LIPG
SCHEMBL26685781 0.78 MEN1 (0.40) BCL2BCL2L1MCL1P2RX7KDM4E
Carbamic Acid SCHEMBL28131089 0.78 TPMT (0.57) KDM4ETPMTCYP1A2CYP3A4TSHR
Carbamic Acid SCHEMBL28102259 0.78 LMNA (0.44) LMNAKDM4ETPMTCYP1A2CYP3A4
Carbamic Acid SCHEMBL28155281 0.76 TPMT (0.60) KDM4ETPMTCYP1A2CYP3A4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112312909-A Compounds for the treatment of kinase-dependent disorders 埃克塞里艾克西斯公司 2021-02-02 CN disclosed